In a recent study, published in The Journal of Neuroscience, researchers adopted a novel approach to dyskinesia by treating it as a “bad motor memory.”
They discovered that inhibiting a protein called Activin A could stop dyskinesia symptoms and essentially erase the brain’s “bad memory” response to certain Parkinson’s therapies.
Rather than seeking an entirely new treatment, researchers aimed to find a way to prevent dyskinesia from developing in the first place.